ClinicalTrials.gg
Not yet recruitingNCT07856784CARE2Updated Oct 29, 2026

Cognitive and Behavioral Approaches to Reduce Binge Eating and Excess Weight in Adolescents (Online)

An interventional study of Cognitive-Behavioral Therapy for Adolescent Binge Eating and Lifestyle Behavioral Obesity Intervention in Binge Eating, Overweight and Obesity and Eating Disorders in Adolescence, sponsored by Indiana University. Not yet recruiting at 1 site in United States. Open to participants aged 12 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Indiana University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 29, 2026Primary outcomes revisedNewly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
159
Allocation
Randomized
Ages
12 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 116 studies in Bulimia with a site in United States — 14 open to participants now, 22 under way, none of them phase 3. Bulimia · United States.

Planned enrollment
18th of 101
159 · median 59
Started
2026
with 6 others
No phase
74 of 116
9 open now
Primary completion
2030-01
later than 17 of 21 live
Registered
116th of 116
by date

Among the 116 studies in Bulimia with a site in United States, this one is the 18th largest by planned enrollment of the 101 interventional ones that give a count, is one of 7 that started in 2026, is one of 74 with no phase, reaches primary completion later than 17 of the 21 other live ones, and was the 116th registered.

Bulimia

173 studies on the registry are indexed under Bulimia; 32 are open to participants now.

Browse Bulimia studies →

Open to participants now

14 of the 116 studies in Bulimia with a site in United States are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 18 Bulimia studies recruiting now, 4 (22%) set no upper age limit and 13 (72%) stop at 75 or younger; 2 take children under 18; 3 take healthy volunteers.

This study: 12 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 116 studies in Bulimia with a site in United States, or all of them as a file.
02

Study summary

This study will compare a psychological treatment (cognitive-behavioral therapy; CBT-BED) and a lifestyle beahvioral obesity intervention (LBOI) for adolescents who experience binge eating and have overweight or obesity. These treatments will be compared to each other and to a control condition that involves self-monitoring eating and mood using an "app". Participants can be located in most states in the United States. All participation occurs remotely by telehealth. The goal is to learn which approach works best for reducing binge eating and excess weight in this age group.

Read the detailed description

Binge eating is the most prevalent eating disorder but has the lowest rate (\<4%) of receiving eating disorder treatment. Binge eating often begins in adolescence and is related to obesity, physical and mental health problems, and psychological distress. Yet, there are virtually no established treatments, and no clear standard of care, for adolescents with binge eating. Evidence-based treatments exist for adults, including psychological treatments (e.g., CBT-BED) and lifestyle behavioral obesity intervention (LBOI), but how well these treatments work for adolescents remains largely unknown. LBOI is an effective treatment for adolescent obesity, but has only been tested as additional outcomes (not the initial goal) for binge eating. There is an urgent need for research to establish the efficacy of interventions for adolescents with binge eating to improve adolescents' health and quality of life. This study will conduct a randomized controlled trial (RCT) in which adolescents are randomized to Psychological Treatment (cognitive behavioral therapy for binge eating, or CBT-BED), Behavioral Treatment (lifestyle health behavioral treatment for obesity, or LBOI), or Active Control. In this study, we will compare both CBT-BED and LBOI to each other and to an Active Control. Active Control is daily self-monitoring (emotions, eating, exercise) on an "app", mimicking real-world self-help, followed by choice of CBT-BED or LBOI.

03

Conditions studied

  • Binge Eating
  • Overweight and Obesity
  • Eating Disorders in Adolescence

Keywords

  • cognitive-behavioral therapy
  • obesity
  • psychotherapy
  • randomized controlled trial
  • binge eating
  • eating disorder
  • adolescent
  • child
  • parent
04

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Be in the age range ≥12 years old and ≤17 years old;
  2. Have a that places them above the 85th percentile based on their age and sex;
  3. Report 4 episodes of binge eating (feeling a loss of control while eating) per month for the past 3 months;
  4. Be available for participation in the study for 18 months.

Exclusion criteria

Exclusion Criteria:

  1. Have a medical or psychiatric condition that would require a higher level of care, such as hospitalization or intensive outpatient care (e.g., neurological disorder, psychotic disorders, suicidality);
  2. Have a medical or psychiatric condition that would prohibit them from engaging in behavioral treatment or moderate physical activity (e.g., cardiovascular problems);
  3. Have uncontrolled medical condition(s) (e.g., uncontrolled diabetes or hypertension);
  4. Be pregnant or breastfeeding;
  5. Be taking medication(s) or participating in treatment(s) that could influence weight or appetite;
  6. Have begun taking hormonal less than 3 months prior, as this can be related to weight changes;
  7. Have a developmental or cognitive disorder that would interfere with engaging in cognitive treatment;
  8. Have a concurrent feeding/eating disorder (e.g., bulimia nervosa); or
  9. Be participating in another clinical research study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
159 participants (estimated)

Study arms

  • Experimental
    Cognitive-Behavioral Therapy

    Cognitive-behavioral therapy for binge-eating disorder (CBT-BED) for adolescents with binge eating and overweight or obesity, delivered remotely by telehealth.

    Behavioral: Cognitive-Behavioral Therapy for Adolescent Binge Eating

  • Experimental
    Lifestyle Behavioral Obesity Intervention

    Lifestyle behavioral obesity intervention (LBOI) for adolescents with binge eating and overweight or obesity, delivered remotely by telehealth.

    Behavioral: Lifestyle Behavioral Obesity Intervention

  • Active comparator
    Active Control

    Active control: daily self-monitoring of eating, emotions, and physical activity via an "app," similar to real-world digital self-help. At the end of the initial period, individuals are presented with descriptions of CBT-BED and LBOI, choose their preferred treatment, and receive it.

    Other: Active Control

Interventions

  • BehavioralCognitive-Behavioral Therapy for Adolescent Binge Eating

    Cognitive-behavioral therapy for binge-eating disorder (CBT-BED) for adolescents with binge eating and overweight or obesity, delivered remotely by telehealth. Sessions target cognitive and emotional drivers of binge eating through coping skills, problem-solving triggers, cognitive restructuring, and executive-function skill training; parent sessions focus on communication and support.

    Also known as: CBT-BED

  • BehavioralLifestyle Behavioral Obesity Intervention

    Lifestyle behavioral obesity intervention (LBOI) for adolescents with binge eating and overweight or obesity, delivered remotely by telehealth. Sessions provide nutrition and physical-activity prescriptions to create a modest calorie deficit and sustainable lifestyle habits and problem-solve nonadherence; parent sessions focus on the home food environment.

    Also known as: LBOI, Intensive Health Behavior Lifestyle Treatment, Behavioral Obesity Treatment, Behavioral Weight Loss

  • OtherActive Control

    Self-monitoring eating, emotions, and exercise daily in a digital "app" that is similar to real-world self-help.

    Also known as: Self-monitoring

06

What researchers measure

Primary outcomes

  1. Binge Eating Episode Frequency

    Eating episodes will be assessed by the Eating Disorder Examination

    Time frame: End of treatment (6 months)

  2. Weight (e.g., Percent Loss)

    Percent body mass index change

    Time frame: End of treatment (6 months)

Secondary outcomes

  1. Eating Disorder Severity

    Global eating-disorder psychopathology will be assessed by the Eating Disorder Examination (scores range from 0 through 6; higher scores indicate more severe psychopathology).

    Time frame: End of treatment (6 months)

  2. Weight-related Quality of Life score

    Weight-related quality of life will be assessed by questionnaire.

    Time frame: End of treatment (6 months)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — de-identified data will be shared with qualified researchers with ethics board approval and a data use agreement.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2030, 38 months later.

Of 67 non-industry interventional studies with no phase under Bulimia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 52. This study's planned 38 months is above that.

Counting every sponsor, half of 69 studies reached it within 26 months; a quarter within 10 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2026
First posted
Oct 5, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Jan 31, 2030
CompletionEst.
Jan 31, 2031
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionWeight (e.g., Percent Loss): how it is measured was reworded
Oct 29, 2026
Secondary outcomes
1 description edited
What changed in the outcomes
  • DescriptionEating Disorder Severity: how it is measured was reworded
Oct 29, 2026
Registered
First appeared on the registry
Oct 5, 2026
Show all 2 updates
  1. Oct 29, 2026
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionWeight (e.g., Percent Loss): how it is measured was reworded
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionEating Disorder Severity: how it is measured was reworded
    + 1 other change: verification date
  2. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07856784
Lead sponsor
Indiana University
Responsible party
Janet Lydecker (Associate Professor, Indiana University) — Principal investigator
First posted
Oct 5, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Jan 31, 2030 (estimated)
Completion
Jan 31, 2031 (estimated)
Last update
Oct 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion